Sirolimus‐coated balloon versus everolimus‐eluting stent in de novo coronary artery disease: Rationale and design of the TRANSFORM II randomized clinical trial
Sign Up to like & getrecommendations! Published in 2022 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30358
Abstract: Percutaneous coronary intervention (PCI) with drug‐eluting stent (DES) implantation is a widely adopted strategy for the treatment of de novo coronary artery disease. DES implantation conveys an inherent risk for short‐ and long‐term complications, including… read more here.
Keywords: eluting stent; coronary artery; artery disease; novo coronary ... See more keywords
Serial assessment of de novo coronary lesions after drug-coated balloon treatment analyzed by intravascular ultrasound: A comparison between acute coronary syndrome and stable angina pectoris.
Sign Up to like & getrecommendations! Published in 2021 at "International journal of cardiology"
DOI: 10.1016/j.ijcard.2021.01.049
Abstract: BACKGROUND This study aimed to assess the serial changes in de novo coronary lesions, including acute coronary syndrome (ACS), treated with a drug-coated balloon (DCB). METHODS In this retrospective single-center study, the intravascular changes in… read more here.
Keywords: coronary lesions; procedure; acute coronary; post procedure ... See more keywords
De novo coronary artery disease in graves’ disease. coincidence?
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Community Hospital Internal Medicine Perspectives"
DOI: 10.1080/20009666.2018.1514934
Abstract: ABSTRACT Hyperthyroidism is associated with increased risk of cardiovascular conditions. We report a case of a 50-year-old woman with no prior cardiac history who presented to the emergency department with shortness of breath, chest pain,… read more here.
Keywords: graves disease; novo coronary; coronary artery; artery disease ... See more keywords
Drug-eluting balloons with provisional bail-out or adjunctive stenting in de novo coronary artery lesions-a systematic review and meta-analysis.
Sign Up to like & getrecommendations! Published in 2018 at "Cardiovascular diagnosis and therapy"
DOI: 10.21037/cdt.2017.10.09
Abstract: Background Efficacy of drug-eluting balloons (DEB) for treatment of de novo coronary lesions remains controversial. The present systematic review and meta-analysis of randomised controlled trials assessed DEB with bare-metal stents (BMS) and also DEB with… read more here.
Keywords: bms; drug eluting; novo coronary; meta analysis ... See more keywords
Long-Term Clinical Outcomes of Drug-Coated Balloon Treatment for De Novo Coronary Lesions
Sign Up to like & getrecommendations! Published in 2023 at "Yonsei Medical Journal"
DOI: 10.3349/ymj.2022.0633
Abstract: Purpose Data are limited on the long-term efficacy and safety of drug-coated balloon (DCB) treatment in comparison to drug-eluting stent (DES) for de novo coronary lesions. We investigated the long-term clinical outcomes of DCB treatment… read more here.
Keywords: long term; novo coronary; coronary lesions; treatment ... See more keywords
Long-term outcomes of less drug-eluting stents by the use of drug-coated balloons in de novo coronary chronic total occlusion intervention: A multicenter observational study
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2023.1045859
Abstract: Background Data on drug-coated balloons (DCB) for de novo coronary chronic total occlusion (CTO) are limited. We aimed to investigate the long-term outcomes of substitution of drug-eluting stents (DES) by DCB. Methods We compared the… read more here.
Keywords: long term; novo coronary; group; drug coated ... See more keywords